Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
4.700
-0.070 (-1.47%)
Jan 14, 2025, 4:00 PM EST - Market closed
Aldeyra Therapeutics Market Cap
Aldeyra Therapeutics has a market cap or net worth of $279.88 million as of January 14, 2025. Its market cap has increased by 31.09% in one year.
Market Cap
279.88M
Enterprise Value
222.75M
1-Year Change
31.09%
Ranking
Category
Stock Price
$4.70
Market Cap Chart
Since May 2, 2014, Aldeyra Therapeutics's market cap has increased from $37.20M to $279.88M, an increase of 652.37%. That is a compound annual growth rate of 20.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2025 | 284.10M | -4.41% |
| Dec 31, 2024 | 297.20M | 43.92% |
| Dec 29, 2023 | 206.50M | -49.34% |
| Dec 30, 2022 | 407.60M | 75.39% |
| Dec 31, 2021 | 232.40M | -12.73% |
| Dec 31, 2020 | 266.30M | 63.98% |
| Dec 31, 2019 | 162.40M | -25.44% |
| Dec 31, 2018 | 217.80M | 67.54% |
| Dec 29, 2017 | 130.00M | 93.16% |
| Dec 30, 2016 | 67.30M | 2.12% |
| Dec 31, 2015 | 65.90M | 63.93% |
| Dec 31, 2014 | 40.20M | 8.06% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.26B |
| UnitedHealth Group | 479.18B |
| Novo Nordisk | 385.14B |
| Johnson & Johnson | 342.03B |
| AbbVie | 309.55B |
| Merck & Co. | 251.07B |
| AstraZeneca | 207.72B |
| Thermo Fisher Scientific | 207.43B |